We recently reported that reduced BDNF is associated with the development of one of the metabolic diseases, metabolic dysfunction-associated steatohepatitis (MASH), in two independent genetically engineered mouse lines with reduced BDNF expression [50]. This evidence concerns the gene BDNF and metabolic disease.